Patients with H3K27M-mutant diffuse midline glioma (DMG) have no proven effective therapies. ONC201 has recently demonstrated efficacy in these patients, but the mechanism behind this finding remains unknown. We assessed clinical outcomes, tumor sequencing, and tissue/cerebrospinal fluid (CSF) correlate samples from patients treated in two completed multisite clinical studies. Patients treated with ONC201 following initial radiation but prior to recurrence demonstrated a median overall survival of 21.7 months, whereas those treated after recurrence had a median overall survival of 9.3 months. Radiographic response was associated with increased expression of key tricarboxylic acid cycle–related genes in baseline tumor sequencing. ONC201 treatment increased 2-hydroxyglutarate levels in cultured H3K27M-DMG cells and patient CSF samples. This corresponded with increases in repressive H3K27me3 in vitro and in human tumors accompanied by epigenetic downregulation of cell cycle regulation and neuroglial differentiation genes. Overall, ONC201 demonstrates efficacy in H3K27M-DMG by disrupting integrated metabolic and epigenetic pathways and reversing pathognomonic H3K27me3 reduction. Significance: The clinical, radiographic, and molecular analyses included in this study demonstrate the efficacy of ONC201 in H3K27M-mutant DMG and support ONC201 as the first monotherapy to improve outcomes in H3K27M-mutant DMG beyond radiation. Mechanistically, ONC201 disrupts integrated metabolic and epigenetic pathways and reverses pathognomonic H3K27me3 reduction. This article is featured in Selected Articles from This Issue, p. 2293
10 February 2022 in Journal of Orthopaedic Experience & Innovation
Introduction: Since 1999, orthopedic surgery has noted significant gaps in racial and gender diversity. A 2007 study demonstrated that diversity in orthopedic surgery lagged behind other specialties. Our study’s purpose was to evaluate changes in orthopedic surgery applicant and resident diversity from 2007 to 2019 and to compare current levels of diversity between applicants and residents alongside 7 other specialties. Methods: Using public demographic data, our study evaluated racial and gender demographics of medical school graduates, residency applicants, and residents from 2007 to 2019 for orthopedic surgery and 7 additional specialties. Furthermore, diversity metrics between orthopedic surgery applicants and residents were compared. Results: From 2007 to 2019, the proportion of minority applicants increased by 26%, while the proportion of female applicants increased by 64% (p<0.001). Orthopedic surgery experienced a 10% decrease in minority resident representation, despite individual increases in some areas (p=0.004). Meanwhile, female representation increased 24% among orthopedic residents (p<0.001). When compared to other specialties in 2019, orthopedic surgery had the lowest proportions of minority and female residents (p<0.001*). Discussion: Since 2007, orthopedic surgery experienced growths in minority and female applicant representation. However, additional efforts are needed to address the gaps in minority and female representation in orthopedic residencies compared to other specialties.
10 June 2022 in Clinical Gastroenterology and Hepatology